Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 868

Results For "IT"

10284 News Found

Doctors at Yashoda successfully treated advanced-stage laryngeal cancer
Biotech | April 25, 2022

Doctors at Yashoda successfully treated advanced-stage laryngeal cancer

Deputy Mayor from Addis Ababa (Ethiopia) battled out a rare laryngeal cancer at Yashoda Hospitals Hyderabad


Marskans Pharma acquires Dubai based Access Healthcare
News | April 25, 2022

Marskans Pharma acquires Dubai based Access Healthcare

Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region


Aleor Dermaceuticals receives USFDA approval for Clobestasol
Drug Approval | April 25, 2022

Aleor Dermaceuticals receives USFDA approval for Clobestasol

Clobetasol Propionate Foam, 0.05% has an estimated market size of US $ IO million for twelve months ending Dec 2021 according to IQVIA


Shilpa Medicare receives NoC for biosimilar Aflibercept
Biotech | April 25, 2022

Shilpa Medicare receives NoC for biosimilar Aflibercept

Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab


Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours
Biotech | April 25, 2022

Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours

Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine


Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya
News | April 25, 2022

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya

April 25th is commemorated as World Malaria Day


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency
Biotech | April 23, 2022

NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency

Heavy bleeding after giving birth is globally a leading cause of death in new mothers


IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol
News | April 23, 2022

IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol

All the capex is being met through internal accruals only


Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK
Biotech | April 23, 2022

Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK

The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences